Neurovascular Devices Market Trends, and Forecast, 2032

Market Research Future (MRFR) predicts the Neurovascular Devices Market size to be worth more than USD 4.2 billion by 2030

Neurovascular Devices Market

Table Of Contents

Neurovascular devices encompass a range of devices which are used for neurovascular management. The rise of neurovascular devices such as brain aneurysms, carotid artery disease, and others are likely to warrant of advanced devices which can prevent the possibility of strokes and other diseases. The global neurovascular devices market report by Market Research Future (MRFR) comprises a comprehensive analysis of the current state and future predictions for the period of 2012 to 2030 (forecast period).

Market Scope

Market Research Future (MRFR) predicts the Neurovascular Devices Market size to be worth more than USD 4.2 billion by 2030. MRFR also forecasts a 5.7% growth rate in the global market during the evaluation period (from 2022 to 2030). It is driven by the rise of neurovascular diseases and development of minimally invasive procedures.

Investments by government organizations for management of neurological conditions can bode well for the market. This is exemplified by the use of funds amounting to USD 6.6 billion by the NHS in the U.K. Clinical trials being conducted for new methods and procedures can encourage market growth. Endovascular treatments are gaining traction with many patients opting it as a method for acute ischemic stroke.

However, high procedural costs and lack of skilled physicians can dampen the market growth prospects.


The global neurovascular devices market is segmented by product, therapeutic application, and end-user.

On the basis of the product, the market is segmented into, aneurysm coiling & embolization devices, neurothrombectomy devices, cerebral balloon angioplasty and stenting systems, and support device. Aneurysm coiling & embolization devices are sub-segmented into liquid embolic, embolic coils, and flow diversion devices. Embolic coils, a part of aneurysm coiling & embolization devices segment, are further segmented into detachable coils and pushable coils. Similarly, neurothrombectomy devices segment is sub-segmented into suction and aspiration devices and retrieval systems. The support device segment is sub-segmented into microcatheters and microguidewires. The cerebral balloon angioplasty and stenting systems segment is sub-segmented into carotid artery stents and embolic protection systems. Embolic protection systems are further divided into distal filter devices and balloon occlusion devices.

By therapeutic application, the global neurovascular devices market is categorized into hemorrhagic stroke and ischemic strokes.

By end-users, the market is segmented into hospitals & clinics and ambulatory surgical units.

Regional Analysis

The Americas, Asia Pacific (APAC), Europe, and the Middle East & Africa are regions considered for measuring the value and volume of the global neurovascular devices market.

The Americas are touted to dominate the global neurovascular devices market owing to high prevalence of neurovascular diseases. According to a study by the Methodist DeBakey Cardiovascular Journal in 2014, close to 1 million strokes occur annually due to intracranial atherosclerotic disease. The large healthcare expenditure of nations in the region and presence of major players can further regional market growth.

APAC is predicted to exhibit a stellar growth rate during the forecast period owing to the growth of economies of China and India. Demand for minimally invasive surgeries by the geriatric populace can fuel the demand in the global neurovascular devices market trend.

Competitive Outlook

Evasc, OxfordEndovascular, Gynesonics, Delaware Corporation, TERUMO CORPORATION, Merit Medical Systems, Inc., Secant Group, LLC, Rapid Medical, Neuravi, Medikit co., ltd., Stryker, Abbott, MicroPort Scientific Corporation, W. L. Gore & Associates, Inc., Medtronic, Penumbra, Inc., Johnson & Johnson Services, Inc., Blockade Medical, LLC., and Sensome are major players of the global neurovascular devices market. Product launches, acquisitions, and distribution agreements are strategies being implemented by players to sustain their position in the market. In 2020, Arterio Medical submitted the results of the clinical trial of Endura Embolization System in bifurcation systems. The results demonstrated the low relapse of coils and provide immediate cerebral aneurysm occlusion.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: [email protected]


Leave a Reply

    © 2024 Crivva. All Rights Reserved.